Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 481–504 of 4,558 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: obesity Clear all

Conditions: Obesity, Overweight
Interventions: Enriched lifestyle intervention; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 13 Years to 15 Years · Female only
Enrollment: 215 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Obesity
Interventions: Fee-for-Service Model (FFS, In clinic individual visits), Patient Centered Medical Home (PCMH, In clinic group visits), Disease Management (DM, Phone group visits); Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 20 Years to 75 Years
Enrollment: 1,432 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Type 2 Diabetes Mellitus
Interventions: exenatide, placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 196 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 10
States / cities: Peoria, Arizona • Jacksonville, Florida • Orlando, Florida + 7 more

Conditions: Overweight, Obesity
Interventions: zenagamtide, Placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 950 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 41
States / cities: Anniston, Alabama • Birmingham, Alabama • Montgomery, Alabama + 36 more

Conditions: Oxidized Low Density Lipoprotein
Interventions: Cardio formulation, Placebo; Dietary Supplement
Lead sponsor: Supplement Formulators, Inc.; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Binge Eating Disorder Associated With Obesity, Binge Eating Disorder
Interventions: Digital; Other
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Metabolic Syndrome X, Hyperlipidemia, Hypertension
Interventions: Almond enriched diet, Low fat caloric diet; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 123 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Satiety
Interventions: Low fat cookie, Mango fruit; Other
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Obesity, Morbid, Diabetes Mellitus, Type 2, Gastric Bypass
Interventions: Not listed
Lead sponsor: CPL Associates; Other
Eligibility: 18 Years to 95 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 2
States / cities: Buffalo, New York • Williamsville, New York

Conditions: Diabetes, Pre-diabetes, Obesity
Interventions: Metformin; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 10 Years to 79 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Morbid Obesity, Non-alcoholic Fatty Liver Disease
Interventions: low carbohydrate diet, low-fat diet; Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 55 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Insulin Resistance
Interventions: VO2 Max, DEXA, Peripheral Microvascular Reactivity, Skeletal Muscle Insulin Sensitivity, Non-Oxidative Glucose Disposal, Muscle tissue Biopsy; Other
Lead sponsor: AdventHealth Translational Research Institute; Other
Eligibility: 30 Years to 65 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Stress, Obesity, Overeating
Interventions: Nutritional Counseling, Mindfulness Intervention; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Healthy
Interventions: Nutramigen (Flavor and Type of Infant Formula), Enfamil, milk-based formula; Other
Lead sponsor: Monell Chemical Senses Center; Other
Eligibility: 2 Weeks to 4 Weeks
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Overweight, Diabetes Mellitus, Type 2
Interventions: eloralintide and tirzepatide, Tirzepatide; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 25
States / cities: Tucson, Arizona • Los Alamitos, California • Los Angeles, California + 20 more

Conditions: Duchenne Muscular Dystrophy (DMD)
Interventions: Semaglutide (Rybelsus®), Placebo; Drug · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Obstructive Sleep Apnea, Pregnancy, Obesity, Sleep
Interventions: Not listed
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older · Female only
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Overweight, Obese, Metabolic Disorders, Postpartum
Interventions: Not listed
Lead sponsor: Kaiser Permanente; Other
Eligibility: Female only
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Overweight, Obesity
Interventions: Dietary supplement containing plant derived phenolics, Microcrystaline cellulose; Dietary Supplement
Lead sponsor: Brightseed; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Addison, Illinois

Conditions: Healthy Volunteers, Obesity
Interventions: Ghrelin, Saline; Drug
Lead sponsor: Jenny Tong, MD, MPH; Other
Eligibility: 18 Years to 40 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Overweight and Obesity
Interventions: NOURISH+, Wellness Group; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 730 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Obesity
Interventions: growth monitoring, Growth Monitoring plus Family-based Behavioral Counseling; Behavioral
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 4 Years to 8 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Knoxville, Tennessee

Conditions: Healthy, Deficiency Disease
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: Not listed
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Tobacco Use Disorder, Weight Gain
Interventions: Varenicline, Lorcaserin; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Search by objective public record fields.

Examining the Feasibility of Collaborative Care Treatment for Overweight Adolescents

Rural Engagement in Primary Care for Optimizing Weight Reduction

Effect on Weight Loss of Exenatide Versus Placebo

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

To Assess the Efficacy and Safety of the Cardio Formulation in Reducing Oxidized LDL

A Self-Guided Mobile Intervention for Adults With Binge Eating and Obesity

Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons

Effects of Fresh Mango Pulp Consumption on Satiety and Cardiometabolic Health

Endotoxin and Intestinal Flora Before and After Gastric Bypass or Banding in Diabetics

Metformin at the Cellular Level and Dosing for Diabetes Mellitus (DM)

Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates

Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training

Sensitive Periods in Early Flavor Learning

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy

Predictors of De-novo Development of Obstructive Sleep Apnea in Pregnancy

Post-delivery Maternal-offspring Obesity and Metabolic Risk After a Prepregnancy Weight-loss Intervention

Dietary Supplementation on Fat Oxidation

Effect of Ghrelin on Decision-Making

NOURISH+: Nourishing Our Understanding of Role Modeling to Improve Support and Health

A Pilot Study of the Efficacy and Program Cost-effectiveness of Prevention Plus for Childhood Obesity

Effects of Dietary Carbohydrate and Fat on Hormones

Lorcaserin for Preventing Weight Gain Among Smokers